62135-455 : Acarbose 100 mg Oral Tablet
NDC: | 62135-455 |
Labeler: | Chartwell Rx, LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Acarbose |
Dosage Form: | Oral Tablet |
Application #: | ANDA202271 |
Rev. Date: |
NDC Package Codes:
- 62135-455-90: 90 TABLET IN 1 BOTTLE (62135‑455‑90)
Active Ingredients:
- Acarbose
Dosage Strength:
- 100 mg
Pharmaceutical Classes:
- alpha Glucosidase Inhibitors [MoA]
- alpha-Glucosidase Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 62135-453 Acarbose 25 mg Oral Tablet by Chartwell Rx, LLC
- 62135-454 Acarbose 50 mg Oral Tablet by Chartwell Rx, LLC
- 0054-0140 Acarbose 25 mg Oral Tablet by Roxane Laboratories, Inc
- 0054-0141 Acarbose 50 mg Oral Tablet by Roxane Laboratories, Inc
- 0054-0142 Acarbose 100 mg Oral Tablet by Roxane Laboratories, Inc
- 0115-1150 Acarbose 25 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories, Inc.
- 0115-1151 Acarbose 50 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories, Inc.
- 0115-1152 Acarbose 100 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories, Inc.
- 0378-2820 Acarbose 25 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-2821 Acarbose 50 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-2822 Acarbose 100 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 11788-039 Acarbose 25 mg Oral Tablet by Aiping Pharmaceutical
- 11788-040 Acarbose 50 mg Oral Tablet by Aiping Pharmaceutical
- 11788-041 Acarbose 100 mg Oral Tablet by Aiping Pharmaceutical
- 16252-523 Acarbose 25 mg Oral Tablet by Cobalt Laboratories
- 16252-524 Acarbose 50 mg Oral Tablet by Cobalt Laboratories
- 16252-525 Acarbose 100 mg Oral Tablet by Cobalt Laboratories
- 23155-147 Acarbose 25 mg Oral Tablet by Heritage Pharmaceuticals Inc.
- 23155-148 Acarbose 50 mg Oral Tablet by Heritage Pharmaceuticals Inc.
- 23155-149 Acarbose 100 mg Oral Tablet by Heritage Pharmaceuticals Inc.
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 62135-454Next: 62135-456 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.